Rigel.com
| Top rigel sites |
- Title
- Rigel Pharmaceuticals
- Meta Description
- Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.
- Meta Keywords
- Rigel, rigel pharmaceuticals, novel small molecule, small molecule, drug discovery, target validation, target discovery, clinical programs, clinical trial, clinical development, r406, r788, r256, r348, r548, r549, r507, immune thrombocytopenic purpura, itp, adult itp, chronic itp, immune thrombocytopenia, immune disorders, immunology, autoimmune, oncology, immuno-oncology, syk, syk kinase, spleen tyrosine kinase, syk inhibitor, inflammatory disease, autoimmune disease, acute myeloid leukemia, AML, non small cell lunch cancer, NSCLC, solid tumors, cancer, axl, axl kinase, asthma, metabolic diseases, ampk, mdm2 inhibitor, ligase, kinase inhibitor, ubiquitin ligase, jak1, jak2, jak3, janus tyrosine kinase, pkc theta, pkc inhibitors, jak inhibitors, fostamatinib, muscle wasting, ocular gvhd, jak, pkc, muscle disorders, ampk activators, astrazeneca, jak3 inhibitor, oral syk, dry eye, ocular gvhd, daiichi sankyo, TGF beta inhibitors, TGFb inhibitors, bergenbio ...
| Server | Apache/2.4.6 (CentOS |
| X-Powered-By | W3 Total Cache/0.9.4 |
| X-Pingback | http://www.rigel.com |
| Pragma | public |
| Cache-Control | max-age=0, no-cache |
| Vary | Accept-Encoding,User |
| X-Mod-Pagespeed | 1.9.32.4-7251 |
| Content-Encoding | gzip |
| Keep-Alive | timeout=2, max=200 |
| Connection | Keep-Alive |
| Content-Type | text/html; charset=U |